Related content

Capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer

By Lee S.-H.   Lee J.   Park J.   Park S.   Lee K.-E.   Lee S.   Nam E.   Park J.   Kim K.   Jung C.   Park Y.   Yoon S.   Kang W.   Lee M.   Park K.   Im Y.-H.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 223-231

Humana Press, Inc

Access to resources Recommend Favorite

Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer

By Wist Erik   Sommer Hilde   Østenstad Bjørn   Risberg Terje   Bremnes Yngve   Mjaaland Ingvild  

Acta Oncologica, Vol. 43, Iss. 2, 2004-03 ,pp. : 186-189

Informa Healthcare

Access to resources Recommend Favorite

A randomized phase II non-comparative study of pemetrexedcarboplatin and gemcitabinevinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients

By                    

International Journal of Oncology, Vol. 42, Iss. 5, 2013-01 ,pp. : 1778-1785

Spandidos Publications

Access to resources Recommend Favorite

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

By Minckwitz Gunter   Jonat Walter   Fasching Peter   Bois Andreas   Kleeberg Ulrich   Lück Hans-Joachim   Kettner Erika   Hilfrich Jörn   Eiermann Wolfgang   Torode Julie   Schneeweiss Andreas  

Breast Cancer Research and Treatment, Vol. 89, Iss. 2, 2005-01 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Sequential versus simultaneous use of vinorelbine and capecitabine at the same dosage as first-line chemotherapy for patients with metastatic breast cancer

By Gu Shiyang   Zhang Ping   Jia Zhen   Wang Biyun   Zhang Jian   Wang Zhonghua   Guo Haiyi   Wang Jialei   Zhao Xinmin   Hu Xichun  

The Chinese-German Journal of Clinical Oncology, Vol. 9, Iss. 9, 2010-09 ,pp. : 528-535

Springer Publishing Company

Access to resources Recommend Favorite